美安医药 (836163.OC)

+ 收藏

利润表(美安医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 227,332,949.38442,766,530.00189,606,083.37443,799,861.81234,219,616.72
 营业收入(元) 227,332,949.38442,766,530.00189,606,083.37443,799,861.81234,219,616.72
二、营业总成本(元) 223,615,196.97427,737,108.21181,084,297.94427,168,565.07228,774,309.29
 营业成本(元) 197,517,903.61373,033,715.99155,862,845.17358,395,589.42190,430,415.13
 研发费用(元) 2,793,050.037,189,737.163,466,909.4518,357,214.8416,881,396.45
 营业税金及附加(元) 305,671.22896,539.34432,738.281,172,442.10616,018.53
 销售费用(元) 9,078,189.0119,056,537.449,587,297.4023,077,127.1410,032,219.54
 管理费用(元) 8,140,115.0517,916,477.847,964,255.1620,005,584.118,617,355.24
 财务费用(元) 5,780,268.059,644,100.443,770,252.486,160,607.462,196,904.40
  其中:利息费用(元) -9,586,017.823,722,885.025,078,902.432,320,745.17
  其中:利息收入(元) -143,264.3158,206.6865,646.1251,595.82
三、其他经营收益
 加:投资收益(元) -55,524.03366,458.6026,679,315.59532.26
 资产处置收益(元) ---10,817.95-
 资产减值损失(元) -21,869.93-6,277,352.22-25,780.45-4,029,544.67-326,558.90
 信用减值损失(元) -254,801.12763,873.761,291,608.04-480,315.37-1,214,374.85
 其他收益(元) 115,051.75477,636.91443,719.952,018,566.87377,069.27
四、营业利润(元) 3,556,133.1110,049,104.2710,597,791.5740,830,137.114,281,975.21
 加:营业外收入(元) 3,335.00121,750.0710,328.508,953.40-
 减:营业外支出(元) 28,612.73132,509.2640,500.00349,649.24649.08
五、利润总额(元) 3,530,855.3810,038,345.0810,567,620.0740,489,441.274,281,326.13
 减:所得税费用(元) 2,949,329.265,778,282.863,125,363.909,935,541.974,135,339.16
六、净利润(元) 581,526.124,260,062.227,442,256.1730,553,899.30145,986.97
(一)按经营持续性分类
  持续经营净利润(元) 581,526.124,260,062.227,442,256.17-145,986.97
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 1,205,000.615,135,750.568,285,928.2134,135,016.343,940,669.18
  少数股东损益(元) -623,474.49-875,688.34-843,672.04-3,581,117.04-3,794,682.21
 扣除非经常性损益后的净利润(元) 1,205,000.614,426,929.717,555,179.8012,493,693.423,580,338.80
七、每股收益
 一、基本每股收益(元) 0.030.120.190.790.09
 二、稀释每股收益(元) 0.030.120.190.790.09
八、其他综合收益(元) 197,900.68150,528.64-83,687.39-
 归属于母公司股东的其他综合收益(元) 101,483.4777,194.17-83,687.39-
 归属于少数股东的其他综合收益(元) 96,417.2173,334.47---
九、综合收益总额(元) 779,426.804,410,590.867,442,256.1730,637,586.69145,986.97
 归属于母公司所有者的综合收益总额(元) 1,306,484.085,212,944.738,285,928.2134,218,703.733,940,669.18
 归属于少数股东的综合收益总额(元) -527,057.28-802,353.87-843,672.04-3,581,117.04-3,794,682.21
公告日期 2024-08-262024-04-252023-08-252023-04-252022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院